| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | Chief Financial Officer | Common Stock | 0 | $0 | $10.80 | 16 Dec 2025 | Direct |
| Evoke Pharma Inc | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 17 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EVOK | Evoke Pharma Inc | 16 Dec 2025 | 3 | $0 | 4 | Chief Financial Officer | 17 Dec 2025, 16:00 |
| EVOK | Evoke Pharma Inc | 20 Mar 2025 | 1 | +$14,463 | 4 | Chief Financial Officer | 24 Mar 2025, 16:30 |
| EVOK | Evoke Pharma Inc | 28 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 29 Jan 2025, 16:30 |
| EVOK | Evoke Pharma Inc | 07 Aug 2024 | 1 | $0 | 4 | Chief Financial Officer | 08 Aug 2024, 17:11 |
| EVOK | Evoke Pharma Inc | 22 May 2024 | 0 | $0 | 3 | Chief Financial Officer | 30 May 2024, 18:09 |